stockportfolio.pro
Cryoport, Inc. (CYRX)
Industrials · Integrated Freight & Logistics · NasdaqCM
Cryoport, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.68M | $11.95M | $19.63M | $33.94M | $78.70M | $222.61M | $237.28M | $168.66M | $156.77M | $176.18M |
| Gross profit | $3.10M | $5.97M | $10.24M | $17.35M | $36.33M | $96.58M | $103.87M | $75.33M | $69.66M | $83.05M |
| Net income | $-13.11M | $-7.90M | $-9.56M | $-18.33M | $-32.69M | $-275.53M | $-37.33M | $-99.59M | $-114.76M | $78.30M |
| Net margin | -170.8% | -66.1% | -48.7% | -54.0% | -41.5% | -123.8% | -15.7% | -59.0% | -73.2% | 44.4% |
Source: Cryoport, Inc. SEC filings (10-K). 16 years of history available in the interactive view.
Explore 16 years of Cryoport, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CYRX in your portfolio →
Cryoport, Inc. financial history by metric
Compare Cryoport, Inc. with peers
About Cryoport, Inc.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Cryoport, Inc. — frequently asked questions
What is Cryoport, Inc.'s revenue?
Cryoport, Inc. (CYRX) reported revenue of $176.18M for fiscal year 2025, up 12.4% from the prior year, according to its SEC filings.
Is Cryoport, Inc. profitable?
Yes. CYRX earned net income of $78.30M in fiscal 2025, a net margin of 44.4%.
What is CYRX's P/E ratio?
Cryoport, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Cryoport, Inc. growing?
CYRX's revenue grew at roughly 17.5% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Cryoport, Inc. have?
As of fiscal year 2025, CYRX carried roughly $186.34M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Cryoport, Inc.'s gross margin?
CYRX's gross margin was 47.1% in fiscal 2025 — gross profit of $83.05M on revenue of $176.18M.
What is Cryoport, Inc.'s market cap?
Cryoport, Inc. (CYRX) has a market capitalization of about $734.87M, based on the latest data in our nightly-refreshed cache.
When does Cryoport, Inc.'s fiscal year end?
CYRX's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Cryoport, Inc.'s official SEC filings (10-K and 10-Q), covering 16 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.